CHUN LI, PH.D.

Assistant Director for Education

Chun Li, Ph.D. is an Asso­ciate Pro­fes­sor of Population and Quantitative Health Sciences.  He has exten­sive expe­ri­ence in sta­tis­ti­cal genet­ics research and genetic data analy­sis.  He is cur­rently work­ing on devel­op­ing meth­ods for detect­ing somatic changes using next-generation sequenc­ing data.  He is also inter­ested in devel­op­ing meth­ods to effi­ciently mine elec­tronic med­ical records.  Active in col­lab­o­ra­tive research, he has been work­ing with inves­ti­ga­tors in var­i­ous fields such as can­cer epi­demi­ol­ogy, clin­i­cal phar­ma­col­ogy, oph­thal­mol­ogy, car­dio­vas­cu­lar dis­ease, autism, type 2 dia­betes, etc.  He has pub­lished in Nature Genet­ics, New Eng­land Jour­nal of Med­i­cine, Blood, Amer­i­can Jour­nal of Human Genet­ics, Bioinformatics, etc.

Affiliations

CWRUlogowTag240x120CC-logo

Recent Publications

  1. Kim, SH, Oh, JS, Chun, HJ. Reply: Pleural and intra-abdominal long-term drainage: comparison of a novel double-loop and a conventional single-loop catheter. Diagn Interv Radiol 2026; : . PubMed PMID:42553045 .
  2. Lee, DE, Lim, G, Ko, M, Kim, M, Chun, JS, Lee, B, Kim, M, Kim, K, Choi, BK, Seo, J et al.. Early and High-Dose Glucocorticoid Use and Survival in Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Multicenter Target Trial Emulation. Clin Pharmacol Ther 2026; : . PubMed PMID:42552645 .
  3. Filzmayer, M, Petix, M, Quarta, L, Orlandi, F, Goyal, JA, Carmignani, L, Briganti, A, Micali, S, Shariat, SF, Wenzel, M et al.. Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. Ann Surg Oncol 2026; : . PubMed PMID:42552493 .
  4. Yoo, JS, Tak, KY, Cho, HS, Han, JW, Jang, JW, Lee, J, Yang, H, Kim, CW, Lee, HL, Kim, HY et al.. Comparison of Second-line Hepatic Arterial Infusion Chemotherapy and Tyrosine Kinase Inhibitors in Advanced Hepatocellular Carcinoma. Radiology 2026; 320 (2): e253280. PubMed PMID:42550027 .
  5. Tseng, YH, Wu, PL, Kang, EY, Chen, KJ, Wang, NK, Liu, L, Chou, HD, Ho, MC, Chu, SM, Hwang, YS et al.. Retinopathy of prematurity epidemiology and treatment trend in a tertiary medical center in Taiwan: From 2016 to 2023. Taiwan J Ophthalmol 2026; 16 (2): 310-317. PubMed PMID:42549255 PubMed Central PMC13431199.
  6. Echere, J, Afolayan, OK, Tate, M, Hubbard, Q, Arzu, I, Shah, SJ, Chun, SG, Anakwenze, CP. Evaluating Minority Participation in Radiation Oncology Clinical Trials and the Impact of COVID-19 on Enrollment in a Large Integrated Academic Satellite Network. JCO Oncol Adv 2026; 3 (1): . PubMed PMID:42549174 PubMed Central PMC13431056.
  7. Jung, KU, Lee, SR, Park, J, Kim, HO, Kim, H, Song, HS, Lee, JY, Kim, YB, Jo, J, Park, JE et al.. Preoperative 18F-FDG PET/CT as a surgical triage tool for synchronous neoplasm detection in acute left-sided obstructive colorectal cancer: a two-institution retrospective cohort study. Front Surg 2026; 13 : 1871410. PubMed PMID:42548845 PubMed Central PMC13429909.
  8. Chun, H, Ju, H, Hwang, SM. T cell-based immunotherapy in solid tumors: mechanistic barriers and emerging opportunities. BMB Rep 2026; : . PubMed PMID:42544055 .
  9. Lee, J, Lee, MY, Kim, HS, Park, JW, Moon, GH, Park, JB, Kim, HJ, Kim, SJ, Chun, YS. Neddylation of NFATc1 and Runx2 regulates osteoclast-osteoblast balance and represents a dual-action therapeutic target for postmenopausal osteoporosis. Exp Mol Med 2026; : . PubMed PMID:42543398 .
  10. Scheipner, L, Baudo, A, Jannello, LMI, Siech, C, Angelis, M, Bello, FD, Tian, Z, Saad, F, Shariat, SF, Briganti, A et al.. Comparisons of Novel Risk Stratification Models to the Current cT1a/b Staging in Incidental Prostate Cancer. Prostate 2026; : . PubMed PMID:42542968 .
Search PubMed